The Clinical Potential of Senolytic Drugs

Keyphrases

• Senescent Cells 100%
• Senolytics 100%
• Clinical Potential 100%
• Clinical Trials 60%
• Frailty 40%
• Physiological Resilience 40%
• Type 1 Diabetes Mellitus (T1DM) 20%
• Aging 20%
• Induced Apoptosis 20%
• Chronic Conditions 20%
• Genetic Approach 20%
• Age-related 20%
• Intervertebral Disc 20%
• Chronic Disease 20%
• Pulmonary Fibrosis 20%
• Healthspan 20%
• Osteoporosis 20%
• Comorbidity 20%
• Multiple Chronic Conditions 20%
• Radiation Damage 20%
• Aging Process 20%
• Aging Mechanism 20%
• Disease-associated 20%
• Fatal Infection 20%
• Cardiac Dysfunction 20%
• Testing Effect 20%
• Cellular Accumulation 20%
• One-at-a-time 20%
• Accelerated Aging 20%
• Functional Deficits 20%
• Multiple Diseases 20%
• Pharmacological Approaches 20%
• Vascular Calcification 20%
• Disc Degeneration 20%
• Aging Characteristics 20%
• Approach Delay 20%
• Geriatric Medicine 20%
• Liver Steatosis 20%
• Accumulation Age 20%
• Vascular Hyporeactivity 20%
• Age-related Illnesses 20%
• Multiple-ages 20%

Medicine and Dentistry

• Clinical Trial 100%
• Disease 66%
• Multiple Chronic Conditions 66%
• Frailty 66%
• Lifespan 33%
• Aging 33%
• Geriatrics 33%
• Geriatric Syndrome 33%
• Programmed Cell Death 33%
• Chronic Disease 33%
• Pulmonary Fibrosis 33%
• Healthspan 33%
• Diabetes Mellitus 33%
• Osteoporosis 33%
• Medicine 33%
• Fatty Liver 33%
• Intervertebral Disk Degeneration 33%
• Accelerated Aging 33%
• Comorbidity 33%